联化科技(002250.SZ)子公司台州联化通过日本PMDA认证

智通财经网03-18

联化科技(002250.SZ)发布公告，公司子公司联化科技(台州)有限公司(“台州联化”)于近日收到日本独立行政法人医药品医疗器械综合机构(PMDA)签发的《医药品适合性调查结果通知书》，涉及客户定制原料药产品。台州联化本次顺利通过了日本PMDA认证，表明公司医药业务相关产品具备向日本市场供应的资质，这将为公司医药的定制生产及拓宽国际市场带来新的动力，并提高公司医药业务的综合竞争力，公司将有机会...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2420445069?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-03-18 15:42","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2420445069","market":"other","top_or_hot":-1,"title":"联化科技(002250.SZ)子公司台州联化通过日本PMDA认证","media":"智通财经网","content":"<div>\n<p>联化科技(002250.SZ)发布公告，公司子公司联化科技(台州)有限公司(“台州联化”)于近日收到日本独立行政法人医药品医疗器械综合机构(PMDA)签发的《医药品适合性调查结果通知书》，涉及客户定制原料药产品。台州联化本次顺利通过了日本PMDA认证，表明公司医药业务相关产品具备向日本市场供应的资质，这将为公司医药的定制生产及拓宽国际市场带来新的动力，并提高公司医药业务的综合竞争力，公司将有机会...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantrfp1103833.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>联化科技(002250.SZ)子公司台州联化通过日本PMDA认证</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n联化科技(002250.SZ)子公司台州联化通过日本PMDA认证\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-03-18 15:42 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantrfp1103833.shtml><strong>智通财经网</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>联化科技(002250.SZ)发布公告，公司子公司联化科技(台州)有限公司(“台州联化”)于近日收到日本独立行政法人医药品医疗器械综合机构(PMDA)签发的《医药品适合性调查结果通知书》，涉及客户定制原料药产品。台州联化本次顺利通过了日本PMDA认证，表明公司医药业务相关产品具备向日本市场供应的资质，这将为公司医药的定制生产及拓宽国际市场带来新的动力，并提高公司医药业务的综合竞争力，公司将有机会...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantrfp1103833.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK0118","symbol_name":"金融改革","start_time":0,"source_url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantrfp1103833.shtml","article_id":"2420445069","we_media_id":null,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/hkstock/ggscyd/2024-03-18/doc-inantrfp1103833.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2420445069","pubTimestamp":1710747720,"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"联化科技发布公告，公司子公司联化科技(台州)有限公司于近日收到日本独立行政法人医药品医疗器械综合机构签发的《医药品适合性调查结果通知书》，涉及客户定制原料药产品。股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK0118":"金融改革","BK0229":"化学制品","BK0070":"员工持股","BK0188":"融资融券","BK0028":"国家队","002250":"联化科技"},"translate_title":"Taizhou Lianhua, a subsidiary of Lianhua Technology (002250. SZ), passed the PMDA certification in Japan","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"002250":1},"content_text":"联化科技(002250.SZ)发布公告，公司子公司联化科技(台州)有限公司(“台州联化”)于近日收到日本独立行政法人医药品医疗器械综合机构(PMDA)签发的《医药品适合性调查结果通知书》，涉及客户定制原料药产品。台州联化本次顺利通过了日本PMDA认证，表明公司医药业务相关产品具备向日本市场供应的资质，这将为公司医药的定制生产及拓宽国际市场带来新的动力，并提高公司医药业务的综合竞争力，公司将有机会获得战略合作伙伴更多的高级中间体及原料药项目，并对公司未来的发展及经营业绩产生积极的影响。\n\n股市回暖，抄底炒股先开户！智能定投、条件单、个股雷达……送给你>>\n\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","kind":null,"is_publish_news":true,"is_publish_highlight":false,"is_publish_live":null,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.24.2","shortVersion":"4.24.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2420445069"}